2018 Payment Schedule Test Updates

The table below reflects Records of Decision associated with laboratory tests under the Laboratory Services Act in BC.

LSA ROD #

Approvals Granted

LSA2018-017

Introduction of Telomere Length (TL) testing for Telomere Biology Disorders (TBDs) by adding two new Provisional (P) fee items, P93048 and P93049, to the Laboratory Services Outpatient Payment Schedule.

Effective November 1, 2018, the Ministry of Health (MOH) has approved the addition of Telomere Length (TL) testing on a provisional (P) basis for a 12-month period. Testing will be restricted to Repeat Diagnostics Inc. and is restricted to referrals by a clinical Hematologist for patients with clinical and/or laboratory evidence of Telomere Biology Disorders (TBDs) and to genetically-related candidate stem cell donors for patients with identified TBD. 

LSA2018-016

Effective November 1, 2018, the Laboratory Services Outpatient Payment Schedule will be amended as follows: 

Addition of three new fee items

  • P90647 – Trichomonas vaginalis (TV) detection by NAAT – urine or swab $18.54
    Notes:
    1. Not payable with P90648 GC/CT detection by NAAT – urine or swab
    2. Not payable with P90784 Trichomonas Antigen Test or 90785 Trichomonas and/or Candida, direct examination
    3. Not payable with P90649 GC/CT/TV detection by NAAT – urine or swab
    4. TV detection by NAAT (P90647 and P90649), should not be used for general screening. The test should only be performed on symptomatic individuals and those in high risk groups.
    5. If two or more specimens are submitted on the same day, laboratory medicine physician approval for testing both is required.
  • P90648 – Gonorrhea/Chlamydia trachomatis (GC/CT) detection by NAAT – urine or swab $16.80
    Notes:
    1. Not payable with P90649 GC/CT/TV detection by NAAT – urine or swab
    2. Not payable with P90647 TV detection by NAAT
    3. If two or more specimens are submitted on the same day, laboratory
  • P90649 – Gonorrhea/Chlamydia trachomatis/Trichomonas vaginalis (GC/CT/TV) detection by NAAT – urine or swab $31.47
    Notes:
    1. Not payable with P90648 GC/CT detection by NAAT – urine or swab
    2. Not payable with P90784 Trichomonas Antigen Test or 90785 Trichomonas and/or Candida, direct examination
    3. Not payable with P90647 TV detection by NAAT
    4. If two or more specimens are submitted on the same day, laboratory medicine physician approval for testing both is required.
    5. TV detection by NAAT (P90647 and P90649), should not be used for general screening. The test should only be performed on symptomatic individuals and those in high risk groups.

Amendment to notes for fee items P90784 and 90785

  • P90784 - Trichomonas Antigen Test
    Add note: Not payable with TV detection by NAAT (90647 and 90649).
  • 90785 - Trichomonas and/or Candida, direct examination
    Add note: Not payable with 90784 Trichomonas Antigen Test, or TV detection by NAAT (P90647 and P90649).

12 Months after implementation

  • Remove fee items 90645 – Chlamydia antigen, and
    90650 – Chlamydia culture
  • Remove P90784 – Trichomonas Antigen Test
  • Amend the description of fee item 90785 - Trichomonas and/or Candida, direct examination as follows, and remove the previously added note (see above)
    90785 - Candida, direct examination

Removal of four existing fee items

  • 90651 – Chlamydia trachomatis using NAAT – urine
  • 90652 – Chlamydia trachomatis using NAAT – swab
  • 90653 – Gonorrhea by NAAT - urine
  • 90654 – Gonorrhea by NAAT – swab
LSA2018-015

Amended Standard Outpatient Laboratory Requisition HLTH 1901 05/30/2018.

Effective August 3, 2018 the Ministry of Health has approved an amended Standard Outpatient Laboratory Requisition. Implementation and utilization of the Standard Outpatient Laboratory Requisition (HLTH 1901 05/30/2018) is required by February 28, 2019.

LSA 2018-011

Effective July 1, 2018, the Ministry of Health has amended the names of fee items 91226 and 91636 on the Laboratory Services Outpatient Payment Schedule, as follows:

Fee item 91226 - B-glucosidase-quantitative will have a title change as follows: Barbiturates-quantitative 

Fee item 91636 - Fat, microscopic examination - balance 3 day – feces will have a title change as follows: Fat, balance 3 day-feces

LSA 2018-010

Fee revision of Bile acids, total in the Laboratory Services Outpatient Payment Schedule.

Effective August 1, 2018 the Ministry of Health has amended the fee amount for 91241 – Bile acids, total, from $36.58 to $32.36.

LSA2018-009

Effective July 1, 2018, the Ministry of Health has amended the billing notes for fee item P91022 on the Laboratory Services Outpatient Payment Schedule.

Ophthalmologists in BC can now refer for Muscle-specific Tyrosine Kinase Antibody (MuSK Ab) testing.

LSA2018-005

Effective June 1, 2018, the Ministry of Health has amended the fee amount for five antinuclear antibody testing fee items in the Laboratory Services Outpatient Payment Schedule, as follows:

  1.  Fee item 90280 – Antinuclear antibodies – immunofluorescence screen from $23.82 to $20.44.
  2.  Fee item 90281 – Antinuclear antibodies by sensitive EIA from $17.76 to $16.24.
  3.  Fee item 90120 –Extractable Nuclear Antigens from $30.60 to $24.99.
  4.  Fee item 90121 – Antinuclear antibodies – specific detection by multiplex immunoassay from $27.65 to $38.64.
  5. Fee item 90035 – Anti DNA from $20.22 to $28.41.
LSA2018-003

Introduction of two new fee items for MALDI-TOF testing in the Laboratory Services Outpatient Payment Schedule. 

Effective June 1, 2018, the Ministry of Health has approved the introduction of two new MALDI-TOF fee items, P90752 for non-stool specimens and P90753 for stool specimens, at the fee of $6.84, in the Laboratory Services Outpatient Payment Schedule. This Record of Decision (ROD) rescinds the October 25, 2017 ROD LSA2017-024.

LSA2018-002

Repatriation of Thiopurine Metabolites (TM) testing to British Columbia from out-of-province/out-of-country, and addition of a new Provisional (P) fee item P92277 – Thiopurine Metabolites, to the Laboratory Services Outpatient Payment Schedule.

Effective May 1, 2018, the Ministry of Health (MOH) has approved the addition of Thiopurine Metabolites (TM) testing on a provisional (P) basis for a one year period. Testing will be restricted to Victoria General Hospital and is restricted to referrals from specialists prescribing thiopurine medications, and to patients with active inflammatory bowel disease and/or adverse effects thought to be due to thiopurine toxicity.

LSA2017-023

Repatriation of infliximab and anti-infliximab antibody testing from Alberta to British Columbia.

Effective May 1, 2018, the Ministry of Health (MOH) has approved the repatriation and funding of Infliximab (IFX) and anti-infliximab antibody (IFXA) testing on a provisional basis (P) for a one year period. IFX and IFXA testing will be restricted to St. Paul’s Hospital (SPH).